More on HCWB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+46.5% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

HCW Biologics (NQ:HCWB)
Delayed: 1.81 -0.1 (5.24%)
Prev. Close $1.91  
Open$1.91 
52 Wk High$ 
52 Wk Low$ 
Day High$1.98 
Day Low$1.70 
P/E N/A  
EPS$ 
Volume133,708 

Friends, Peers and Foes (?): S1GE34, 0A3M, A1SN34, ABBV, ASND (more...)

Sep 10, 2026 06:02 AM Form 8-K HCW Biologics Inc. For: Sep 09
Sep 8, 2026 08:50 AM HCW Biologics signs distribution deal with Akron Biotech for HCW11-006
Sep 8, 2026 08:50 AM HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
Sep 2, 2026 09:00 AM HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
Aug 28, 2026 04:42 PM Form S-1/A HCW Biologics Inc.
Aug 25, 2026 09:02 AM HCW Biologics advances two cancer drug candidates using TGF-β/IL-15
Aug 25, 2026 09:00 AM HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
Aug 20, 2026 03:02 PM HCW Biologics (HCWB) files for 1.24M share offering by selling stockholders
Aug 20, 2026 02:59 PM Form S-1 HCW Biologics Inc.
Aug 14, 2026 03:31 PM Form 10-Q HCW Biologics Inc. For: Jun 30
View All Articles

Entities mentioned with HCWB

View All Entities